April 2025 (englisch) Einzelnachweise [Bearbeiten | Quelltext bearbeiten] Tong Zhang, Matthew H
This substantial participant database provides meaningful safety evidence across varied dosing regimens, administration routes (oral and injectable), and treatment durations, making it one of the more extensively studied peptide fragments in human clinical trials
It contains two long-acting peptide analogues: cagrilintide, a synthetic amylin receptor agonist, and semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
GLP-1 RAs were significantly associated with gastrointestinal AEs, and the association was further attributed to liraglutide, dulaglutide, and semaglutide
Alternative Names: MT-II Melanotan 2 Studies and Research Data Neuroprotective and Regeneration Models In murine research involving peripheral nerve injury, Melanotan 2 was suggested to promote neurite outgrowth and partial sensory recovery